Share Price and Basic Stock Data
Last Updated: December 24, 2025, 3:41 pm
| PEG Ratio | 0.15 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Morgan Ventures Ltd operates in the Non-Banking Financial Company (NBFC) sector, focusing on providing financial services. The company’s stock price stood at ₹78.5, with a market capitalization of ₹77.7 Cr. Over the past few quarters, revenue has shown volatility, with sales reported at ₹9.00 Cr in June 2022, declining to negative figures in December 2022 (-₹3.69 Cr) and March 2023 (-₹0.36 Cr). However, a recovery was observed in June 2023, with sales rising to ₹3.59 Cr, and continued growth in subsequent quarters, reaching ₹10.91 Cr by March 2024. This upward trend indicates a potential turnaround in operations, with projected sales of ₹45 Cr for FY 2025, up from ₹23 Cr in FY 2024. The company’s operating profit margin (OPM) has remained robust, peaking at 99.44% in June 2022, suggesting strong operational control amidst fluctuating revenue figures.
Profitability and Efficiency Metrics
Morgan Ventures has reported impressive profitability metrics, highlighted by a return on equity (ROE) of 32% and return on capital employed (ROCE) of 18.3%. The operating profit margin stood at 61.84%, reflecting effective cost management despite revenue fluctuations. The company’s net profit was ₹23 Cr, with quarterly net profit peaking at ₹9.28 Cr in December 2024. Notably, the interest coverage ratio (ICR) was extraordinarily high at 9984.77x, indicating that the company generates sufficient earnings to cover its interest obligations, providing a significant cushion against financial distress. However, the company experienced net losses in certain quarters, such as December 2022 and March 2023, which raises concerns about sustained profitability. The overall efficiency metrics indicate a strong operating framework, but the ability to maintain consistent profitability remains a challenge.
Balance Sheet Strength and Financial Ratios
The balance sheet of Morgan Ventures demonstrates a solid financial foundation, with total assets reported at ₹295 Cr and total liabilities at ₹278 Cr, resulting in a healthy net asset position. The company’s reserves have increased to ₹86 Cr, reflecting retained earnings and prudent financial management. Borrowings stood at ₹178 Cr, indicating a moderate leverage ratio, which is relatively low compared to industry standards. The price-to-book value (P/BV) ratio was notably low at 0.18x, suggesting the stock might be undervalued relative to its book value. This could attract value-oriented investors. Additionally, the cash conversion cycle (CCC) was reported at 0 days, indicating efficiency in managing working capital. However, the company’s reliance on debt to finance its operations could pose risks, especially if revenue generation does not stabilize.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Morgan Ventures reflects a strong promoter commitment, with promoters holding 74.80% of the shares. The public shareholding stood at 25.19%, with a total of 6,197 shareholders as of the latest report. This concentrated promoter ownership may signal confidence in the company’s long-term strategy and governance. The gradual increase in the number of shareholders from 4,355 in December 2022 to 6,197 indicates growing investor interest and confidence in the company’s recovery trajectory. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may indicate a lack of institutional backing, which could affect liquidity and market perception. The reliance on retail investors could also pose risks during market downturns, as retail sentiment tends to be more volatile.
Outlook, Risks, and Final Insight
The outlook for Morgan Ventures appears cautiously optimistic, with potential revenue growth driven by a recovery in sales and strong profitability metrics. However, several risks loom, including the volatility in revenue, as indicated by past quarterly performance, and the company’s reliance on debt financing to support operations. If revenue does not stabilize, it may impact profitability and increase financial strain. Furthermore, the lack of institutional investors could hinder stock liquidity and market perception. The company must navigate these challenges while leveraging its strong operational metrics to maintain investor confidence. In a favorable scenario, sustained revenue growth coupled with effective cost management could enhance profitability and drive share price appreciation. Conversely, failing to stabilize revenue could lead to increased scrutiny from investors and potential declines in share value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.9 Cr. | 1.49 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 7.93 Cr. | 0.79 | 8.75/0.75 | 23.3 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 465 Cr. | 63.8 | 130/59.1 | 40.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 14.8 Cr. | 16.1 | 34.4/15.0 | 11.0 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 37.8 Cr. | 84.0 | 162/74.8 | 20.2 | 238 | 1.19 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,120.78 Cr | 455.87 | 53.36 | 522.46 | 0.22% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.00 | 7.04 | -3.69 | -0.36 | 3.59 | 3.93 | 4.56 | 10.91 | 5.89 | 12.48 | 14.46 | 12.42 | 5.53 |
| Expenses | 0.05 | 0.07 | 0.07 | 2.12 | 0.08 | 0.10 | 0.06 | 0.17 | 0.83 | 0.12 | 0.06 | 0.33 | 2.11 |
| Operating Profit | 8.95 | 6.97 | -3.76 | -2.48 | 3.51 | 3.83 | 4.50 | 10.74 | 5.06 | 12.36 | 14.40 | 12.09 | 3.42 |
| OPM % | 99.44% | 99.01% | 97.77% | 97.46% | 98.68% | 98.44% | 85.91% | 99.04% | 99.59% | 97.34% | 61.84% | ||
| Other Income | 0.00 | 0.00 | 0.77 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 1.39 | 0.07 | 0.00 | 0.00 | 0.00 |
| Interest | 0.62 | 0.35 | 0.54 | 0.85 | 1.46 | 1.61 | 2.04 | 3.62 | 2.36 | 3.72 | 1.99 | 4.22 | 2.76 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 8.33 | 6.62 | -3.53 | -3.33 | 2.06 | 2.23 | 2.46 | 7.12 | 4.09 | 8.71 | 12.41 | 7.87 | 0.66 |
| Tax % | 27.13% | 11.33% | -25.21% | -18.32% | 35.92% | 11.66% | 25.20% | 32.44% | -22.49% | 36.97% | 25.14% | 14.87% | -57.58% |
| Net Profit | 6.07 | 5.87 | -2.64 | -2.72 | 1.32 | 1.98 | 1.84 | 4.81 | 5.01 | 5.50 | 9.28 | 6.70 | 1.05 |
| EPS in Rs | 6.13 | 5.93 | -2.67 | -2.75 | 1.33 | 2.00 | 1.86 | 4.86 | 5.06 | 5.56 | 9.37 | 6.77 | 1.06 |
Last Updated: August 19, 2025, 1:00 pm
Below is a detailed analysis of the quarterly data for Morgan Ventures Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 5.53 Cr.. The value appears to be declining and may need further review. It has decreased from 12.42 Cr. (Mar 2025) to 5.53 Cr., marking a decrease of 6.89 Cr..
- For Expenses, as of Jun 2025, the value is 2.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.33 Cr. (Mar 2025) to 2.11 Cr., marking an increase of 1.78 Cr..
- For Operating Profit, as of Jun 2025, the value is 3.42 Cr.. The value appears to be declining and may need further review. It has decreased from 12.09 Cr. (Mar 2025) to 3.42 Cr., marking a decrease of 8.67 Cr..
- For OPM %, as of Jun 2025, the value is 61.84%. The value appears to be declining and may need further review. It has decreased from 97.34% (Mar 2025) to 61.84%, marking a decrease of 35.50%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 2.76 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.22 Cr. (Mar 2025) to 2.76 Cr., marking a decrease of 1.46 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.66 Cr.. The value appears to be declining and may need further review. It has decreased from 7.87 Cr. (Mar 2025) to 0.66 Cr., marking a decrease of 7.21 Cr..
- For Tax %, as of Jun 2025, the value is -57.58%. The value appears to be improving (decreasing) as expected. It has decreased from 14.87% (Mar 2025) to -57.58%, marking a decrease of 72.45%.
- For Net Profit, as of Jun 2025, the value is 1.05 Cr.. The value appears to be declining and may need further review. It has decreased from 6.70 Cr. (Mar 2025) to 1.05 Cr., marking a decrease of 5.65 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.06. The value appears to be declining and may need further review. It has decreased from 6.77 (Mar 2025) to 1.06, marking a decrease of 5.71.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 1 | -0 | -0 | 0 | -3 | 1 | 6 | 17 | 12 | 23 | 45 | 46 |
| Expenses | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 0 | 1 | 3 |
| Operating Profit | 3 | -1 | -0 | -0 | -0 | -3 | 1 | 6 | 15 | 10 | 23 | 44 | 44 |
| OPM % | 63% | -196% | -2,900% | 77% | 95% | 91% | 81% | 98% | 97% | 94% | |||
| Other Income | -0 | -0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 1 | -0 | 1 | 0 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 3 | 4 | 2 | 9 | 12 | 14 |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 |
| Profit before tax | 2 | -1 | 0 | 0 | 0 | -3 | -0 | 3 | 11 | 8 | 14 | 33 | 30 |
| Tax % | 1% | 65% | 17% | 33% | -0% | -27% | 100% | 50% | 25% | 19% | 28% | 23% | |
| Net Profit | 2 | -2 | 0 | 0 | 0 | -2 | -0 | 1 | 8 | 7 | 10 | 26 | 23 |
| EPS in Rs | 1.55 | -2.25 | 0.06 | 0.03 | 0.01 | -2.30 | -0.10 | 1.47 | 8.44 | 6.65 | 10.05 | 25.88 | 23.17 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2019-2020 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | 700.00% | -12.50% | 42.86% | 160.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 600.00% | -712.50% | 55.36% | 117.14% |
Morgan Ventures Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2019-2020 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 108% |
| 3 Years: | 40% |
| TTM: | 78% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 201% |
| 3 Years: | 43% |
| TTM: | 65% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 56% |
| 3 Years: | 18% |
| 1 Year: | 28% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 19% |
| 3 Years: | 22% |
| Last Year: | 32% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: December 4, 2025, 3:07 am
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 31 | 29 | 29 | 29 | 29 | 28 | 27 | 29 | 37 | 44 | 54 | 79 | 86 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 38 | 36 | 108 | 156 | 156 | 171 | 178 |
| Other Liabilities | 12 | 10 | 9 | 0 | 0 | 0 | 0 | 1 | 4 | 6 | 9 | 17 | 20 |
| Total Liabilities | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 278 | 295 |
| Fixed Assets | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 | 20 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 9 | 11 | 9 | 2 | 2 | 0 | 51 | 53 | 139 | 197 | 210 | 255 | 268 |
| Other Assets | 35 | 38 | 39 | 37 | 37 | 37 | 24 | 23 | 20 | 19 | 19 | 3 | 7 |
| Total Assets | 53 | 49 | 48 | 39 | 39 | 38 | 76 | 76 | 159 | 216 | 229 | 278 | 295 |
Below is a detailed analysis of the balance sheet data for Morgan Ventures Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Reserves, as of Sep 2025, the value is 86.00 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Mar 2025) to 86.00 Cr., marking an increase of 7.00 Cr..
- For Borrowings, as of Sep 2025, the value is 178.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 171.00 Cr. (Mar 2025) to 178.00 Cr., marking an increase of 7.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 295.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 278.00 Cr. (Mar 2025) to 295.00 Cr., marking an increase of 17.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 268.00 Cr.. The value appears strong and on an upward trend. It has increased from 255.00 Cr. (Mar 2025) to 268.00 Cr., marking an increase of 13.00 Cr..
- For Other Assets, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 4.00 Cr..
- For Total Assets, as of Sep 2025, the value is 295.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2025) to 295.00 Cr., marking an increase of 17.00 Cr..
However, the Borrowings (178.00 Cr.) are higher than the Reserves (86.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Mar 2015n n 9m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 3.00 | -1.00 | 0.00 | 0.00 | 0.00 | -3.00 | -37.00 | -30.00 | -93.00 | -146.00 | -133.00 | -127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Inventory Days | -2,230 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 72 | 0 | 0 | -2,230 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Working Capital Days | 1,361 | 11,065 | 658,460 | 4,421 | 7,347 | 1,441 | 415 | 539 | 282 | -6 | ||
| ROCE % | 4% | -3% | 0% | 0% | 0% | -8% | 2% | 7% | 13% | 5% | 11% | 18% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Jun 14 | Jun 13 | Jun 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
| Diluted EPS (Rs.) | 0.04 | -2.41 | 1.75 | -0.23 | 1.29 |
| Cash EPS (Rs.) | 0.06 | -2.12 | 2.56 | 1.08 | 2.81 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 39.21 | 39.17 | 41.48 | 39.99 | 39.95 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.54 | 4.18 | 4.13 | 4.00 |
| PBDIT / Share (Rs.) | 0.01 | -1.34 | 2.84 | 0.88 | 2.92 |
| PBIT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.19 | 1.83 |
| PBT / Share (Rs.) | 0.00 | -1.53 | 1.77 | -0.58 | 1.17 |
| Net Profit / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
| NP After MI And SOA / Share (Rs.) | 0.04 | -2.31 | 1.49 | 0.00 | 1.72 |
| PBDIT Margin (%) | 0.00 | -246.91 | 68.05 | 21.43 | 73.09 |
| PBIT Margin (%) | 0.00 | -281.26 | 42.39 | -4.83 | 45.73 |
| PBT Margin (%) | 0.00 | -281.31 | 42.38 | -14.09 | 29.19 |
| Net Profit Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
| NP After MI And SOA Margin (%) | 0.00 | -425.48 | 35.68 | -0.05 | 42.89 |
| Return on Networth / Equity (%) | 0.10 | -5.89 | 3.59 | 0.00 | 4.29 |
| Return on Capital Employeed (%) | 0.00 | -3.15 | 3.11 | -0.35 | 3.11 |
| Return On Assets (%) | 0.08 | -4.60 | 2.46 | 0.00 | 2.83 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.15 | 0.15 | 0.21 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.17 | 0.15 | 0.21 |
| Asset Turnover Ratio (%) | 0.00 | 0.01 | 0.07 | 0.07 | 0.07 |
| Current Ratio (X) | 2.49 | 13.52 | 5.19 | 8.13 | 11.95 |
| Quick Ratio (X) | 0.62 | 3.61 | 0.27 | 0.60 | 1.73 |
| Interest Coverage Ratio (X) | 67.43 | -4912.48 | 9984.77 | 2.31 | 4.42 |
| Interest Coverage Ratio (Post Tax) (X) | -11.85 | -8831.33 | 6145.96 | 0.38 | 3.59 |
| Enterprise Value (Cr.) | 7.47 | -1.79 | 14.72 | 11.69 | 11.19 |
| EV / Net Operating Revenue (X) | 0.00 | -3.32 | 3.56 | 2.86 | 2.81 |
| EV / EBITDA (X) | 404.43 | 1.35 | 5.23 | 13.33 | 3.84 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 8.13 | 1.88 | 1.50 | 0.73 |
| Price / BV (X) | 0.33 | 0.11 | 0.18 | 0.15 | 0.07 |
| Price / Net Operating Revenue (X) | 0.00 | 8.14 | 1.88 | 1.50 | 0.73 |
| EarningsYield | 0.00 | -0.52 | 0.19 | 0.00 | 0.58 |
After reviewing the key financial ratios for Morgan Ventures Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Diluted EPS (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 5. It has increased from -2.41 (Mar 15) to 0.04, marking an increase of 2.45.
- For Cash EPS (Rs.), as of Mar 16, the value is 0.06. This value is below the healthy minimum of 3. It has increased from -2.12 (Mar 15) to 0.06, marking an increase of 2.18.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 39.21. It has increased from 39.17 (Mar 15) to 39.21, marking an increase of 0.04.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 0.00. It has decreased from 0.54 (Mar 15) to 0.00, marking a decrease of 0.54.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 0.01. This value is below the healthy minimum of 2. It has increased from -1.34 (Mar 15) to 0.01, marking an increase of 1.35.
- For PBIT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For PBT / Share (Rs.), as of Mar 16, the value is 0.00. This value is within the healthy range. It has increased from -1.53 (Mar 15) to 0.00, marking an increase of 1.53.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 0.04. This value is below the healthy minimum of 2. It has increased from -2.31 (Mar 15) to 0.04, marking an increase of 2.35.
- For PBDIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -246.91 (Mar 15) to 0.00, marking an increase of 246.91.
- For PBIT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.26 (Mar 15) to 0.00, marking an increase of 281.26.
- For PBT Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -281.31 (Mar 15) to 0.00, marking an increase of 281.31.
- For Net Profit Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 8. It has increased from -425.48 (Mar 15) to 0.00, marking an increase of 425.48.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.10. This value is below the healthy minimum of 15. It has increased from -5.89 (Mar 15) to 0.10, marking an increase of 5.99.
- For Return on Capital Employeed (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -3.15 (Mar 15) to 0.00, marking an increase of 3.15.
- For Return On Assets (%), as of Mar 16, the value is 0.08. This value is below the healthy minimum of 5. It has increased from -4.60 (Mar 15) to 0.08, marking an increase of 4.68.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.00. It has decreased from 0.01 (Mar 15) to 0.00, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 2.49. This value is within the healthy range. It has decreased from 13.52 (Mar 15) to 2.49, marking a decrease of 11.03.
- For Quick Ratio (X), as of Mar 16, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 3.61 (Mar 15) to 0.62, marking a decrease of 2.99.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 67.43. This value is within the healthy range. It has increased from -4,912.48 (Mar 15) to 67.43, marking an increase of 4,979.91.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -11.85. This value is below the healthy minimum of 3. It has increased from -8,831.33 (Mar 15) to -11.85, marking an increase of 8,819.48.
- For Enterprise Value (Cr.), as of Mar 16, the value is 7.47. It has increased from -1.79 (Mar 15) to 7.47, marking an increase of 9.26.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has increased from -3.32 (Mar 15) to 0.00, marking an increase of 3.32.
- For EV / EBITDA (X), as of Mar 16, the value is 404.43. This value exceeds the healthy maximum of 15. It has increased from 1.35 (Mar 15) to 404.43, marking an increase of 403.08.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.13 (Mar 15) to 0.00, marking a decrease of 8.13.
- For Price / BV (X), as of Mar 16, the value is 0.33. This value is below the healthy minimum of 1. It has increased from 0.11 (Mar 15) to 0.33, marking an increase of 0.22.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 8.14 (Mar 15) to 0.00, marking a decrease of 8.14.
- For EarningsYield, as of Mar 16, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.52 (Mar 15) to 0.00, marking an increase of 0.52.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morgan Ventures Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.1% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -11.85
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.62
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 3.28 (Industry average Stock P/E: 53.36)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 37, Ring Road, Lajpat Nagar - IV, New Delhi Delhi 110024 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kuldeep Kumar Dhar | Managing Director |
| Mr. Sanjiv Bansal | Independent Director |
| Mr. Yogesh Kumar Gupta | Independent Director |
| Mrs. Madhu | Woman Director |
FAQ
What is the intrinsic value of Morgan Ventures Ltd?
Morgan Ventures Ltd's intrinsic value (as of 24 December 2025) is 83.33 which is 9.64% higher the current market price of 76.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 75.2 Cr. market cap, FY2025-2026 high/low of 141/64.8, reserves of ₹86 Cr, and liabilities of 295 Cr.
What is the Market Cap of Morgan Ventures Ltd?
The Market Cap of Morgan Ventures Ltd is 75.2 Cr..
What is the current Stock Price of Morgan Ventures Ltd as on 24 December 2025?
The current stock price of Morgan Ventures Ltd as on 24 December 2025 is 76.0.
What is the High / Low of Morgan Ventures Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morgan Ventures Ltd stocks is 141/64.8.
What is the Stock P/E of Morgan Ventures Ltd?
The Stock P/E of Morgan Ventures Ltd is 3.28.
What is the Book Value of Morgan Ventures Ltd?
The Book Value of Morgan Ventures Ltd is 97.3.
What is the Dividend Yield of Morgan Ventures Ltd?
The Dividend Yield of Morgan Ventures Ltd is 0.00 %.
What is the ROCE of Morgan Ventures Ltd?
The ROCE of Morgan Ventures Ltd is 18.3 %.
What is the ROE of Morgan Ventures Ltd?
The ROE of Morgan Ventures Ltd is 32.0 %.
What is the Face Value of Morgan Ventures Ltd?
The Face Value of Morgan Ventures Ltd is 10.0.